Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort

Kevin C J Yuen1, Greisa Vila2, Ignacio Bernabeu3

  • 1Departments of Neuroendocrinology and Neurosurgery, Barrow Pituitary Center, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton University School of Medicine, 240 W Thomas Road, Suite 404, Phoenix, AZ, 85013, USA. kevin.yuen@commonspirit.org.

Pituitary
|April 15, 2026
PubMed
Abstract

No abstract available in PubMed .